Additionally, CRT is an important autoantigen targeted by autoantibodies in patients with autoimmune disorders such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) [3]. This evidence concerns the gene CALR and rheumatoid arthritis.